Cambridge WG

A working group with the goal of finding consensus on the creation of potential pandemic pathogens. Account maintained by @marcelsalathe.

[Cambridge WG @cambridgeWG]

Our website was down for a few weeks (everybody needs a Sabbatical from time to time 😅).

We're back with a static version. Some of the previous content (news, about, etc.) will be added in the coming days.

Keeping the site up mostly for historical reasons. Enjoy!

@mlipsitch

[Marc Lipsitch @mlipsitch]

In this clip @SenRandPaul FALSELY claims https://t.co/xUV7gC9vQG that the @cambridgeWG has characterized work at the Wuhan Institute of Virology as gain-of-function.

[Marc Lipsitch @mlipsitch]

Fellow @ASMicrobiology members: ASM seeking member comment on new Public Policy Principles, including a wholesale endorsement of gain-of-function studies on potential pandemic pathogens. Member comments open -- please weigh in (anonymous) https://t.co/EoWo1wqnh1

[Marc Lipsitch @mlipsitch]

#NSABB my written comments here https://t.co/IwYylWFgqD and slightly updated slides https://t.co/4787xBMh2D

[Marc Lipsitch @mlipsitch]

#NSABB Public can email questions and comments for today's open session to [email protected]

[Marc Lipsitch @mlipsitch]

#NSABB Chair Stanley opens with good summary of the first day, incl applying ethics, better global input, defining criteria for GOFoC,...

[Cambridge WG @cambridgeWG]

Some of the Cambridge Working Group members have responded to the risk benefit analysis. Find their responses here: https://t.co/YQSZJVxf6K

[Cambridge WG @cambridgeWG]

The NSABB will meet on January 7 and 8 to discuss the risk and benefit analysis report by Gryphon Scientific: https://t.co/TjrxR1a9FO #GoF

[Marc Lipsitch @mlipsitch]

#NSABB public meeting Monday to hear risks benefits ethics law on #GOF research http://t.co/i3mFWz2hAH @cambridgeWG @safe_sci

[Cambridge WG @cambridgeWG]

Up to 18 labs in U.S. got live anthrax shipments http://t.co/0R8jJHTH0T

[Future of Humanity Institute @FHIOxford]

FHI's Toby Ord calls for restraint and risk assessment of potential pandemic pathogens @cambridgeWG @oxmartinschool http://t.co/WzM0SWSbMf

[Marc Lipsitch @mlipsitch]

Tulane #Burkholderia 4th ex/yr of pathogen poss escaping BSL3/4 via human error http://t.co/novkGonk1G @CDCgov #Ebola, #H5N1 #flu #anthrax

[Martin Enserink @martinenserink]

NIH is moving ahead with its review of risky viroloy studies. Critics say it's being rushed through in secret. http://t.co/Onyu5C0dS7

[Dylan George @dylanbgeorge]

Tom Inglesby et al UPMC | Take-aways from the National Academies’ “Gain of Function” Meeting http://t.co/Z7iO9fVlLj

[Cambridge WG @cambridgeWG]

Gain-of-function research: time for a real debate. Featuring the CWG’s own @mlipsitch and @mimperia http://t.co/5hER2b9dmL

[Cambridge WG @cambridgeWG]

Revealed: 100 #biosafety breaches at UK labs handling potentially deadly diseases. By @iansample http://t.co/OuNgBAPorF

[Cambridge WG @cambridgeWG]

@rocza @Macrophagic already some fed oversight - what we’re aiming for in near term is a better basis for making decisions in oversight.

[Cambridge WG @cambridgeWG]

@Macrophagic hence our call for this deliberative process: make RBAs meaningful & accountable. @rocza

[Cambridge WG @cambridgeWG]

@Macrophagic discretion of the PI and their institution. Reviews are often incomplete. We also lack data to make any RBA effective @rocza

[Cambridge WG @cambridgeWG]

@Macrophagic for gov funding, some review is required at the IBC level for Experiments of Concern. However, this largely at the @rocza